Christian Simon

ORCID: 0000-0002-4156-9143
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Cancer Studies
  • Head and Neck Surgical Oncology
  • Tracheal and airway disorders
  • Salivary Gland Tumors Diagnosis and Treatment
  • Metabolism and Genetic Disorders
  • Reconstructive Surgery and Microvascular Techniques
  • Cancer Diagnosis and Treatment
  • Peptidase Inhibition and Analysis
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Research Studies
  • Particle Detector Development and Performance
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Ear and Head Tumors
  • Parathyroid Disorders and Treatments
  • Bone health and treatments
  • Biomedical Research and Pathophysiology
  • Genetic Neurodegenerative Diseases
  • Healthcare Systems and Practices
  • Diabetes and associated disorders
  • Airway Management and Intubation Techniques
  • Cancer, Hypoxia, and Metabolism
  • Neurological diseases and metabolism
  • Mitochondrial Function and Pathology
  • Health Systems, Economic Evaluations, Quality of Life

University of Lausanne
2015-2024

University Hospital of Lausanne
2015-2024

GTx (United States)
2019-2024

Deleted Institution
2023

Hôpital Beau-Séjour
2022

Inter Metal (Poland)
2022

University of Liverpool
2021

Hospital Italiano de Buenos Aires
2021

Royal Brisbane and Women's Hospital
2021

Institut Gustave Roussy
2021

Jean‐Pascal Machiels Yungan Tao Lisa Licitra Barbara Burtness Makoto Tahara and 95 more Danny Rischin Gustavo Vasconcelos Alves Iane Pinto Figueiredo Lima Brett Hughes Y. Pointreau Sercan Aksoy Simon Laban Richard Greil Martin Burian Marcin Hetnał Jean–Pierre Delord Ricard Mesı́a Miren Taberna John Waldron Christian Simon Vincent Grégoire Kevin J. Harrington Ramona F. Swaby Yayan Zhang Burak Gümüşçü Behzad Bidadi Lillian L. Siu Danny Rischin Brett Hughes Bo Gao Margaret McGrath Richard Greil Dietmar Thurnher Thorsten Fuereder Martin Burian Sylvie Rottey Jean‐Pascal Machiels Paul Clement Stéphanie Henry S. Deheneffe Gustavo Vasconcelos Alves Iane Pinto Figueiredo Lima Josiane Mourão Dias Pedro Rafael Martins De Marchi Milena Perez Mak Andrea Juliana Pereira de Santana Gomes Gilberto de Castro Tatiane Cardoso Motta Mônica Luciana Agostinho Padoan Ana Paula Victorina Sérgio Jobim Azevedo Lillian L. Siu Stephanie Yasmin Brule John Hilton Chang Shu Wang Nathaniel Bouganim Marc Webster John Walker Neil Chua Ángela R. Zambrano Alicia Quiroga Echeverri Oscar Mauricio Niño Gomez Carlos Alberto Ortiz Luis Alejandro Rojas Andrés Cardona Zorilla Olga Marcela Urrego Meléndez Petra Beran Holečková Bohuslav Melichar Jakub Cvek Jana Prausová Milan Vošmik Jean–Pierre Delord Xavier Zasadny Lionnel Geoffrois Yungan Tao Y. Pointreau Rainer Fietkau Marlen Haderlein Andreas Mueller Ursula C. Schroeder Barbara Wollenberg Simon Laban Philipp Ivanyi Viktor Gruenwald Philippe Schafhausen Orit Gutfeld Iris Gluck Aron Popovtzer Amichay Meirovitz Salem Billan Baruch Brenner Aron Popovtzer Dror Limon Lisa Licitra Francesco Perri Francesco Caponigro Martina Violati Daris Ferrari Franco Nolè Federica Bertolini

10.1016/s1470-2045(24)00100-1 article EN The Lancet Oncology 2024-03-29

Abstract There are significant commonalities among several pathologies involving fibroblasts, ranging from auto-immune diseases to fibrosis and cancer. Early steps in cancer development progression closely linked fibroblast senescence transformation into tumor-promoting cancer-associated fibroblasts (CAFs), suppressed by the androgen receptor (AR). Here, we identify ANKRD1 as a mesenchymal-specific transcriptional coregulator under direct AR negative control human dermal (HDFs) key driver of...

10.1038/s41467-024-45308-w article EN cc-by Nature Communications 2024-02-03

Importance: Head and neck cancers often require complex, labor-intensive surgeries, especially when free flap reconstruction is required. Enhanced recovery important in this patient population but evidence-based protocols on perioperative care for are lacking. Objective: To provide a consensus-based protocol optimal of patients undergoing head cancer surgery with reconstruction. Evidence Review: Following endorsement by the Recovery After Surgery (ERAS) Society to develop protocol,...

10.5167/uzh-146921 article EN Archives of Otolaryngology - Head and Neck Surgery 2017-01-01

Both practice environment and patient clinical demographic characteristics are associated with cancer trial enrollment; simultaneous intervention may be required when trying to increase enrollment rates.

10.1200/jop.2012.000598 article EN Journal of Oncology Practice 2013-03-01

Current treatment guidelines for patients with locally advanced head and neck squamous cell carcinoma (HNSCC) recommend multimodal treatment, including chemoradiation therapy (CRT) or surgery followed by radiation, without chemotherapy. The immune checkpoint inhibitor pembrolizumab has previously demonstrated antitumor activity in recurrent and/or metastatic HNSCC large Phase III trials. For disease, Ib data on the use of combination have shown approach to be safe feasible. We describe here...

10.2217/fon-2020-0184 article EN cc-by-nc-nd Future Oncology 2020-06-01

Binaural audio generation (BAG) aims to convert monaural stereo using visual prompts, requiring a deep understanding of spatial and semantic information. However, current models risk overfitting room environments lose fine-grained details. In this paper, we propose new audio-visual binaural model incorporating an conditional normalisation layer that dynamically aligns the mean variance target difference features context, along with contrastive learning method enhance sensitivity by mining...

10.48550/arxiv.2501.02786 preprint EN arXiv (Cornell University) 2025-01-06

To access the long-time outcome and patterns of failure in patients with advanced head neck squamous cell carcinoma (HNSCC). Between 1992 2005 127 (median age 55 years, UICC stage III n = 6, IV 121) primarily inoperable, HNSCC were treated definite platinum-based radiochemotherapy dose 66.4 Gy). Analysed end-points overall survival (OS), disease-free (DFS), loco-regional progression-free (LPFS), development distant metastases (DM), prognostic factors causes death. The mean follow-up time was...

10.1186/1748-717x-6-70 article EN cc-by Radiation Oncology 2011-06-10

Abstract Background We aimed to estimate minimally important difference (MID) for interpreting group‐level change over time European Organisation Research and Treatment of Cancer Quality Life Questionnaire core 30 (EORTC QLQ‐C30) scores in head neck cancer. Methods Data were derived retrospectively from two published EORTC trials. Clinical anchors selected using correlation strength clinical plausibility the given anchor/QLQ‐C30 scale pair. MIDs within‐group between‐group estimated via mean...

10.1002/hed.26363 article EN Head & Neck 2020-07-06

Abstract Purpose: The incidence of human papillomavirus–associated head and neck squamous cell carcinoma (HPV+-HNSCC) is rising worldwide although current therapeutic modalities are efficient in the majority patients, there a high rate treatment failures. Thus, novel combination approaches urgently needed to achieve better disease control patients with HPV+-HNSCC. We investigated safety efficacy fibroblast activation protein (FAP)-targeted CD40 agonist (FAP-CD40) local hypofractionated...

10.1158/1078-0432.ccr-20-4717 article EN Clinical Cancer Research 2021-04-26

Abstract Epigenetic mechanisms oversee epidermal homeostasis and oncogenesis. The identification of kinases controlling these processes has direct therapeutic implications. We show that ULK3 is a nuclear kinase with elevated expression levels in squamous cell carcinomas (SCCs) arising multiple body sites, including skin Head/Neck. loss by gene silencing or deletion reduces proliferation clonogenicity human keratinocytes SCC-derived cells affects transcription impinging on stem cell-related...

10.1038/s41467-023-36410-6 article EN cc-by Nature Communications 2023-02-16

Local recurrence after surgery for head and neck squamous cell carcinoma (HNSCC) remains a common event associated with dismal prognosis. Improving this outcome requires better understanding of cancer populations that expand from postsurgical minimal residual disease (MRD). Therefore, we assessed clonal dynamics in surgical model barcoded HNSCC growing the submental region immunodeficient mice. Clonal substitution massive reduction heterogeneity emerged as hallmarks local recurrence, clones...

10.1016/j.celrep.2018.10.090 article EN cc-by Cell Reports 2018-11-01

Dysphagia represents one of the most serious adverse events after curative-intent treatments with a tremendous impact on quality life in patients head and neck cancers. Novel surgical radiation therapy techniques have been developed to better preserve swallowing function, while not negatively influencing local control and/or overall survival. This review focuses current literature outcomes curative treatment strategies. Available results from recent studies relevant this topic are presented,...

10.3389/fonc.2019.00999 article EN cc-by Frontiers in Oncology 2019-10-22
Coming Soon ...